Case number: 23-cv-01242
Original Request and Complaint
- Exela Pharma Sciences, LLC, Civil Action No. 23-cv-1242 - May 2, 2023*
- FOIA Request from Exela Pharma Sciences, LLC - March 13, 2023*
Interim Responses
- Final CDC Consults Emails Only*
- Final DOJ Consults Emails Only*
- Final FDA Consults Emails Only*
- Final NIH Consults Emails Only*
- Final Emails Only - August 2023*
- Final Emails Only - September 2023*
- Final Emails Only - November 2023*
*This content is in the process of Section 508 review. If you need immediate assistance accessing this content, please submit a request to foiarequest@hhs.gov. Content will be updated pending the outcome of the Section 508 review.